Manoj Joshi, Secretary of Department of Pharmaceuticals administered the cleanliness pledge to department officers with ...

Leading experts to discuss challenges associated with complex therapeutics, including peptides, oligonucleotides and ...

VitiPure portfolio targets pharmacopoeia-grade, low-endotoxin and stability-critical applications, while US facility ...

In-house developed and manufactured biosimilar marks company’s entry into immuno-oncology and aims to improve access to checkpoint inhibitor therapy Dr. Reddy’s Laboratories has launched NIVORZ ...

The healthcare company has unveiled a sweeping rebrand centred on ‘Lasting Health Starts Now’, alongside a move toward the single ‘Novo’ name ...

Post-transaction, the combined stake held by the Promoter and Promoter Group in Granules India fell from 38.02% to 31.08% of ...

Encoded Therapeutics, a clinical-stage biotechnology company, has raised $275 million in Series F financing, providing the ...

The inspection was conducted over five days at the API manufacturing unit located in the Industrial Development Area, ...

The acquisition, approved at the Board meeting held on September 13, 2026, is intended to streamline company’s corporate ...

For India, the opportunity is to combine technological capability with public-health experience, clinical expertise and ...

The winners were announced at the finale held in Bengaluru, in the presence of Kiran Mazumdar-Shaw, Executive Chairperson, ...

Rs 350 crore—will go toward a new, fully backward-integrated Ibuprofen manufacturing unit at IOLCP’s Barnala, Punjab facility ...